[Skip to content]

Enter search here...
Worcestershire Key Documents
.
.

Treatment of Inflammatory Bowel Disease with Biologics (in patients over 15 years of age)

Please note that the clinical key documents are not designed to be printed, but to be viewed on-line.  This is to ensure that the correct and most up to date version is being used.  If, in exceptional circumstances, you need to print a copy, please note that the information will only be valid for 24 hours and should be read in conjunction with the Key Document Supporting Information and/or Key Document intranet page, which will provide approval and review information.

 

Purpose-

To ensure safe, effective and consistent practice in the prescribing, monitoring and management of Biologic medications for patients with Inflammatory Bowel Disease

Following Succesful completion of the pre-screening checks and patient counselling as to the risks of these medications they may then be started on Biologic medication.

The patient must be registered as a new patient on Bluetec (CCG apprvoal system for high cost drugs) via https://www.bueteq-secure.co.uk/Trust/defualt.htm (for Worcestershire CCGs only) select requests and then complete the appropriate initiation form.

Blueteq must also be completed when a treatment is stopped (selecting 'end of treatment'). A new request for that patient should be submitted for any subsequent biologics.

Infliximab

Adalimumab

Vedolizumab

Ustekinumab

Key Document Supporting Information

Document Code -   WAHT-KD-019

Approval Date-

These are the most upto date and should be used until revised versions are in place -

Version

Owner- Helen Osinski

Key Document Supporting Information 

Contact Information

Helen Osinski (Reid)

Senior IBD CNS

Room 32 Aconbury West,

Worcester Royal Hospital.

Bleep 469, extension 33740 (do not leave messages)

Helpline/answerphone - 01905 760732 (33554).

Page last updated: 26 July 2018